Search
for
Sort by
Research 30 of 116
- High incidence of severe hand–foot syndrome during capecitabine–docetaxel combination chemotherapy
- [A patient with advanced recurrent breast cancer who firmly resisted hair loss and was then treated by combination therapy with high-dose toremifene and capecitabine].
- Management of adverse events and other practical considerations in patients receiving capecitabine (Xeloda®)
- Anlotinib or Bevacizumab Combined with Taxane/Capecitabine for the Second-Line or Subsequent Treatment of HER-2 Negative Metastatic Breast Cancer: A Retrospective Cohort Study
- Alopecia and Hair Damage Induced by Oncological Therapy
- Targeted Therapy– and Chemotherapy-Associated Skin Toxicities: Systematic Review and Meta-Analysis
- Skin toxicity induced by chemotherapy or molecular targeted therapy combined with immune checkpoint inhibitors in Asian patients: A literature review by the Japanese Pharmacist-led Oncodermatology Study Team
- Reporting on Adverse Clinical Events
- Cutaneous Side Effects of Chemotherapy and Radiotherapy
- Efluvio anágeno. Hallazgos tricoscópicos
- S-1 induced discoid lupus erythematosus-like lesions and long-term complete response for para-aortic lymph node recurrence of pancreatic ductal adenocarcinoma: a case report
- Toxic Side Effects of Targeted Therapies and Immunotherapies Affecting the Skin, Oral Mucosa, Hair, and Nails
- Dermatological adverse events with taxane chemotherapy
- Drug-Induced Skin, Nail and Hair Disorders
- Drug Reactions Affecting Hair: Diagnosis
- Drug-induced acne
- Molecular targeted therapies for cancer: Sorafenib mono�therapy and its combination with other therapies (Review)
- Malignancy and Cancer Treatment-Related Hair and Nail Changes
- Advances in the Management of Cutaneous Toxicities of Targeted Therapies
- Pathogenesis and treatment options for chemotherapy‐induced alopecia: a systematic review
- Skin Penetration and Permeation Properties of Transcutol® in Complex Formulations
- First-line therapy with gemcitabine and paclitaxel in locally, recurrent or metastatic breast cancer: A phase II study
- Role for the Epidermal Growth Factor Receptor in Chemotherapy-Induced Alopecia
- Persistent major alopecia following adjuvant docetaxel for breast cancer: incidence, characteristics, and prevention with scalp cooling
- Chemotherapy-induced iatrogenic injury of skin: New drugs and new concepts
- Applications and Implications of Heparin and Protamine in Tissue Engineering and Regenerative Medicine
- Alterações dermatológicas em pacientes oncológicos – adultos e crianças
- Dermatologic Conditions of the Early Post-Transplant Period in Hematopoietic Stem Cell Transplant Recipients
- Dermatologic adverse events associated with chemotherapy and targeted anticancer therapy
- <i>Halocnemum strobilaceum</i> (Pall.) M.Bieb.: a review of its botany, phytochemistry, pharmacology and ethnobotany